Value
A growing and collaborative ecosystem
Accelerated innovation in R&D
Queensland is home to globally reputable universities, hospitals, academic centres of excellence, and cutting-edge clinical trial facilities. Our experienced research teams and clinicians foster an environment of high-quality patient care and groundbreaking clinical research, nurturing the next generation of researchers and practitioners. Queensland’s clinical trials ecosystem accelerates the translation of research into improved practices and technologies, supporting startups and scaleups.
Research and Development Tax Incentive Program
Eligible companies can take advantage of the Research and Development (R&D) Tax Incentive program. Learn more about the Research and Development Tax Incentive program.
Eligibility
Generally, activities conducted in Australia during early stage development or clinical trials (phases 0/I, II and III) are likely to meet the eligibility criteria.
There is no Investigational New Drug (IND) requirement in Australia allowing rapid entry into clinical trials under the Clinical Trials Notification scheme (CTN). The CTN is administered by the Therapeutic Goods Administration (TGA).
To find out about CTN, click on the link below.
